World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
25555
World Ranking
2230
National Ranking
925

Overview

Susan H. Eshleman is affiliated with Johns Hopkins University School of Medicine in the United States. Their research primarily focuses on medicine, immunology, and microbiology, with a strong specialization in infectious diseases and virology.

The scientist's work extensively covers topics related to HIV/AIDS research and interventions, including HIV research and treatment, drug development and treatment for HIV/AIDS, and aspects of HIV related to drug use and sexual risk. Their interests also include HIV-related health complications and treatments, as well as SARS-CoV-2 detection and testing, and adolescent sexual and reproductive health.

Frequent publication venues for their work include:

  • UNC Libraries
  • Journal of the International AIDS Society
  • The Lancet HIV
  • PLoS ONE
  • The Journal of Infectious Diseases

Key recent publications by Susan H. Eshleman include:

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women, 2021, New England Journal of Medicine
  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial, 2022, The Lancet
  • Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial, 2020, The Lancet HIV
  • Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083, 2021, The Journal of Infectious Diseases
  • Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality, 2021, Journal of Clinical Investigation

Among frequent collaborators, Susan H. Eshleman has worked closely with Estelle Piwowar-Manning, Myron S. Cohen, Deborah Donnell, Marybeth McCauley, and Beatriz Grinsztejn, contributing to multiple publications alongside these coauthors.

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Beatriz Grinsztejn;Mina C. Hosseinipour;Heather J. Ribaudo;Susan Swindells

  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

    Unknown

  • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

    Susan H. Eshleman;Martin Mracna;Laura A. Guay;Martina Deseyve

  • Effect of universal testing and treatment on HIV incidence - HPTN 071 (popart)

    Richard J Hayes;Deborah Donnell;Sian Floyd;Nomtha Mandla

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

    Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  • Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

    J. B. Jackson;G. Becker-Pergola;L. A. Guay;P. Musoke

  • The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial

    Audrey Pettifor;Catherine MacPhail;Catherine MacPhail;James P Hughes;James P Hughes;Amanda Selin

  • Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012

    Tamara Flys;Dwight V. Nissley;Cassidy W. Claasen;Dana Jones

  • Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure

    Paul Palumbo;Jane C. Lindsey;Michael D. Hughes;Mark F. Cotton

  • Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.

    Avy Violari;Jane C. Lindsey;Michael D. Hughes;Hilda A. Mujuru

  • Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.

    Kenneth H Mayer;Kenneth H Mayer;Kenneth H Mayer;Lisa A Maslankowski;Fang Gai;Wafaa M El-sadr

  • Nevirapine (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP

    Susan H. Eshleman;Donald R. Hoover;Shu Chen;Sarah E. Hudelson

  • Correlates of HIV acquisition in a cohort of black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061

    Beryl A. Koblin;Kenneth H. Mayer;Susan H. Eshleman;Lei Wang

  • Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

    Wei Huang;Susan H. Eshleman;Jonathan Toma;Signe Fransen

  • Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

    Hoosen M Coovadia;Hoosen M Coovadia;Elizabeth R Brown;Mary Glenn Fowler;Tsungai Chipato

  • Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial.

    Thomas J Coates;Michal Kulich;David D Celentano;Carla E Zelaya

  • Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

    Raphael J. Landovitz;Sue Li;Beatriz Grinsztejn;Halima Dawood

  • Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities.

    Kenneth H. Mayer;Lei Wang;Beryl Koblin;Sharon Mannheimer

  • LigAmp for sensitive detection of single-nucleotide differences

    Chanjuan Shi;Susan H Eshleman;Dana Jones;Noriyoshi Fukushima

Frequent Co-Authors

Oliver Laeyendecker
Oliver Laeyendecker Johns Hopkins University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
J. Brooks Jackson
J. Brooks Jackson University of Iowa Hospitals and Clinics
Deborah Donnell
Deborah Donnell Fred Hutchinson Cancer Research Center
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
James P. Hughes
James P. Hughes University of Washington
Myron S. Cohen
Myron S. Cohen University of North Carolina at Chapel Hill
Taha E. Taha
Taha E. Taha Johns Hopkins University
Mary Glenn Fowler
Mary Glenn Fowler Johns Hopkins University
Beatriz Grinsztejn
Beatriz Grinsztejn Oswaldo Cruz Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities in the healthcare and research sectors. One popular pathway is becoming a Certified Professional Coder, which requires obtaining a certified professional coder certification. This certification is essential for those looking to work with medical coding, billing, and healthcare documentation.

Another promising field linked to microbiology is Health Information Management. Professionals in this sector manage healthcare data and patient records, combining clinical knowledge with technology. The demand and compensation for these roles can be reviewed by exploring health information management jobs salary insights.

For those seeking academic qualifications, selecting from the best cahiim accredited him programs online ensures the education received meets industry standards and increases job market readiness.

Lastly, individuals eager to start quickly in the medical field can consider taking online medical billing and coding certificate fast programs. These fast-tracked options provide vital skills and certifications, paving the way to enter healthcare administration with minimal delay.

Best Scientists Citing Susan H. Eshleman

Trending Scientists

Recently Published Articles